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Abstract 
Chronic kidney disease (CKD) is common with hypertension and diabetes mellitus acting as 
major risk factors for its development. Cardiovascular disease is the leading cause of death 
worldwide and the most frequent endpoint of CKD. There is an urgent need for more precise 
methods to identify patients at risk of CKD and cardiovascular disease. Alterations in 
microvascular structure and function contribute to the development of hypertension, diabetes, 
CKD and their associated cardiovascular disease. Homology between the eye and kidney 
suggest that non-invasive imaging of the retinal vessels can detect these microvascular 
alterations to improve targeting of at-risk patients. Retinal vessel-derived metrics predict 
incident hypertension, diabetes, CKD and cardiovascul r disease and add to current renal and 
cardiovascular risk stratification tools. The advent of optical coherence tomography (OCT) 
has transformed retinal imaging by capturing the chorioretinal microcirculation and its 
dependent tissue with near-histological resolution. In hypertension, diabetes and CKD, OCT 
has revealed vessel remodelling and chorioretinal thinning. Clinical and pre-clinical OCT 
have linked retinal microvascular pathology to circulating and histological markers of injury 
within the kidney. The advent of OCT angiography allows contrast-free visualisation of intra-
retinal capillary networks to potentially detect early, incipient microvascular disease. 
Combining OCT’s ‘deep imaging’ with the analytical power of deep learning represents the 
next frontier in defining what the eye can reveal about the kidney and broader cardiovascular 
health. 
 
 
Keywords: chronic kidney disease, hypertension, imaging, microcirculation, ocular, 
proteinuria 
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Abbreviations 
AVR – arteriole-to-venule ratio 
BP – blood pressure 
CKD – chronic kidney disease 
CRAE – central retinal arteriolar equivalents 
CRVE – central retinal venular equivalents 
CVD – chronic kidney disease 
Df – fractal dimension  
eGFR – estimated glomerular filtration rate 
ESRD – end stage renal disease 
OCT – optical coherence tomography 
OCT-A – optical coherence tomography angiography 
GCL – ganglion cell layer 
GBM – glomerular basement membrane 
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Introduction 
Chronic kidney disease (CKD) affects ~10% of the world’s population and its incidence is 
increasing.1 Hypertension and diabetes mellitus are also common w rldwide with an 
estimated prevalence of ~30% and ~10%, respectively; both are important risk factors for the 
development and progression of CKD.2, 3 These systemic diseases are strongly associated 
with incident cardiovascular disease (CVD) and their inter-relationship contributes to CVD 
being the most common endpoint of CKD.4 Current clinical tools lack precision to detect, 
stratify and track individual patients at increased risk of progressive CKD and CVD, and 
prior to end-organ damage. Thus, there is an urgent unmet need for simple, non-invasive 
methods to allow earlier identification and risk stratification of patients at increased risk of 
progressive end-organ injury and subsequent end-stage renal disease (ESRD) and CVD. 
 
Microvessels (luminal diameter <300 µm) regulate tissue perfusion and contribute to 
systemic vascular resistance. This ability is closely linked to endothelial function. Several 
pathophysiological processes may contribute to and be a consequence of endothelial 
dysfunction, with downstream effects on microvessels (Figure 1).5 Alterations in 
microvascular structure and function contribute to the development and progression of 
hypertension, diabetes, CKD and CVD.5-7 Importantly, such changes precede the 
development of end-organ damage8 and appear modifiable.9 Moreover, microvascular 
dysfunction in peripheral beds mirrors dysfunction in visceral beds,10, 11 providing a rationale 
for imaging accessible microvessels, such as those of the eye. Transparency of the ocular 
media allows direct visualisation of the microvasculat re that may be affected by systemic 
diseases such as hypertension, diabetes and CKD. Here, w  discuss the basis for the eye to 
act as a window to the kidney and evidence for the microcirculation of the eye to report risk 
of adverse renal and CVD outcomes.  
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The eye as a window to the kidney  
The eye and kidney have several structural, developmental and organisational similarities that 
support the concept that ocular tissues might reflect renal disease (Figure 2).  
 
Bruch’s membrane and the glomerular basement membrane 
Bruch’s membrane divides the posterior pole of the eye into the retina (a laminated 
neurovascular structure) and choroid (an almost entirely vascular structure), collectively 
termed chorioretinal. Bruch’s membrane and the glomerular basement membrane (GBM) 
both contain a network of α3, α4 and α5 type IV collagen chains.12, 13 Thus, inherited or 
acquired diseases involving type IV collagen can affect both organs; the presence of co-
existent nephropathy and retinopathy in Alport syndrome is a well-described example of this 
(Supplementary figure 1).14, 15 Another example, anti-GBM disease is characterised by the 
development of immunoglobulin-G autoantibodies directed against the α3 chain, which are 
deposited on glomerular and alveolar basement membranes triggering a crescentic 
glomerulonephritis and pulmonary haemorrhage, respectively.16 Similar linear 
immunoglobulin-G deposition in Bruch’s membrane hasbeen reported in patients with anti-
GBM disease who developed concurrent choroidal ischaemia and retinal detachment.17, 18  
 
The arrangement of the choroidal capillary (choriocapillaris) endothelium, Bruch’s 
membrane and the retinal pigment epithelium mirrors that of the glomerular endothelium, 
GBM and podocyte (Figure 2). The pathological relevance of this homology is readily 
appreciated in membrano-proliferative glomerulonephritis type II in which electron dense 
deposits are found on the GBM and on Bruch’s membrane.19 Evidence of complement 
system dysregulation as a key driver of renal and retinal deposit formation in membrano-
proliferative glomerulonephritis20 and drusen deposition on Bruch’s membrane in age-related 
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macular degeneration has extended the link between ey  and kidney to include immune 
regulation.21, 22 
 
Chorioretinal and renal microcirculations 
Development and ultrastructure 
The human retinal circulation develops predominantly by angiogenesis, where new vessels 
bud from pre-existing ones, to supply the inner two- hirds of the retina.23 In the kidney, the 
peritubular capillaries and vasa recta populate the medulla and inner cortex in a similar 
manner.24 In contrast, the choroidal and glomerular endothelium are reported to develop by 
vasculogenesis, where clusters of progenitor cells form islands of de novo vessels giving rise 
to the choriocapillaris and renal corpuscle respectiv ly,24, 25 although for the glomerulus this 
is debated.26 The choriocapillaris endothelium has ~80 nm fenestrations allowing fluid 
exchange within the subretinal space.27 The glomerular endothelium has similarly sized 
fenestrations that facilitate ultrafiltration into Bowman’s capsule.28 
 
Organisation and blood flow 
The retinal and medullary circulations each receive <20% of the total ocular and renal blood 
flow, respectively, despite the high metabolic activity of the retinal photoreceptors and the 
medullary counter-current exchange system. Thus, both regions have a lower oxygen tension 
compared to their choroidal and cortical counterparts c eating matched chorioretinal and 
corticomedullary oxygen gradients (Figure 2). The choroidal circulation receives ~80% of 
ocular blood flow and passively oxygenates key visual apparatus including the pigment 
epithelium and photoreceptors  particularly within the avascular fovea.25 This role demands a 
blood flow that is 4-fold higher per unit mass than the kidney and 10-fold higher than the 
brain,25 indicating the importance of the choroid to global retinal health. Choroidal vascular 
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change may therefore predate the onset of overt retinopathy and, if detectable, might allow 
earlier identification of incipient disease. 
 
Regulation of blood flow 
All components of the renin-angiotensin-aldosterone system are widely expressed throughout 
the retinal and choroidal vascular networks (Figure 2).29 Similar to effects in the kidney, 
angiotensin II acting via type I receptors leads to chorioretinal vasoconstriction30 but may 
also modulate glial-pericyte-vasomotor signalling that maintains retinal neurovascular 
integrity.31 Excessive renin-angiotensin-aldosterone system  activation contributes to the 
pathogenesis of diabetic retinopathy and both diabetic and non-diabetic CKD.32 Moreover, 
renin-angiotensin-aldosterone system inhibition in cli ical trials prevents the development 
and progression of diabetic retinopathy and nephropathy, probably independently of effects 
on blood pressure (BP).32 
 
Within the eye, endothelin-1 (ET-1) mediates vasoconstriction via endothelin-A (ETA) 
receptors which are predominantly localised to choroidal and retinal vascular smooth muscle 
cells. In contrast, endothelin-B (ETB) receptors appear confined to neuronal and glial 
structures.33 Similarly in the kidney, ETA receptors are localised to the vascular smooth 
muscle of glomeruli and vasa recta, whereas ETB receptors are mainly localised to the 
collecting system (Figure 2). Selective ETA receptor blockade in the eye increases retinal 
blood flow and reduces both retinal pericyte apoptosis and retinal thinning in a mouse model 
of type 2 diabetes.34 These effects are mirrored in the kidney where selctive ETA blockade 
ameliorates intra-glomerular hypertension, podocytopa hy and fibrosis to slow CKD 
progression.35, 36 Autonomic innervation in the eye is limited to the choroidal circulation 
where sympathetic activation mediates choroidal vasoconstriction25 in a similar manner to 
effects on intra-renal vessels. Thus, the choroidal microvasculature, rather than retinal 
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vessels, may more accurately reflect the renal microvasculature, particularly in diseases 
characterised by excessive sympathetic activation, such as CKD.1  
 
Retinal imaging, the kidney and cardiovascular disease 
Retinal photography  
Qualitative retinopathy grading (for example microaneurysms, haemorrhages or focal 
arteriolar narrowing) and computer-assisted quantittive retinal vessel calibre analysis of 
digital fundus photographs have been the mainstay of retinal imaging for the last 20 years 
(Supplementary figure 2). As retinopathy reflects established end-organ damage detecting 
changes in retinal vessel calibre that precede thisovert damage may allow earlier 
identification of at-risk patients.37 The most established metrics are derived from arteriolar 
and venular widths from vessels close to the optic dis (Table 1 & Supplementary figure 
2). Novel indices of retinal vascular network geometry such as fractal dimensions (Df) can be 
derived from skeletonised vessel maps from retinal photographs (Figure 3). These indices 
identify suboptimal vascular branching patterns that m y reflect and promote microvascular 
damage in systemic disease.38, 39 The presence and severity of retinopathy, vessel calibre 
change and fractal deviations have been strongly linked to hypertension, diabetes mellitus 
and CKD as well as CVD endpoints. 
 
The retinal circulation - CVD risk factors and outcomes  
Hypertension 
Retinal arteriolar narrowing is thought to reflect increased systemic vascular tone. Large 
cross-sectional studies demonstrate strong, indepennt associations between BP and 
generalised and focal arteriolar narrowing.40 Longitudinal studies have shown that retinal 
arteriolar narrowing is associated with a ~2-fold increased risk of incident hypertension 
independent of age, sex, baseline BP and other CVD risk factors (Supplementary table 1), 
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supporting the concept that retinal microvascular changes precede overt disease and are able 
to identify at-risk individuals. This paradigm has been challenged more recently by data 
suggesting a high prevalence of masked hypertension at the time of retinal imaging as 
detected by ambulatory BP monitoring.41 Additionally, systolic BP and mean arterial pressure 
show an inverse linear relationship with Df in keeping with rarefaction.42-44 This relationship 
holds true in young children with a normal BP (a population who should lack confounding 
pre-existing vascular risk factors) and is independent of retinal arteriolar calibre.45 
 
Diabetes mellitus 
Diabetic retinopathy is associated with systemic vascular complications likely reflecting 
widespread microvascular disease.46 More so than in hypertension, retinal venular widen ng 
is prevalent in diabetes, correlates with severity of retinopathy and predicts progression to 
overt retinopathy suggesting a different pathophysiological basis for the change in vessel 
calibre.47 Wider venules are seen in response to chronic hypoxia48 and associate with 
endothelial dysfunction,49 suggesting they reflect microvascular stress in response to 
metabolic derangement. In support of this concept, higher cholesterol, greater body mass 
index  and worse glycaemic control link to wider retinal venules.50-53 Moreover, wider 
venules and smaller AVR predict incident fasting hyperglycaemia and diabetes over 5 to 10 
years, independent of fasting glucose, insulin levels, body mass index, family history or BP 
(Supplementary table 2).54 Finally, reduced Df in those with diabetes can predict incident 
neuropathy, nephropathy and progressive retinopathy independent of other risk factors for 
microvascular complications although the strength of these associations is modest.55, 56 
 
CKD 
Retinopathy (diabetic, hypertensive or otherwise) is more prevalent in patients with CKD, 
independent of standard CVD risk factors including diabetes and proteinuria.57 Retinopathy 
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severity also shows a graded relationship with declining estimated glomerular filtration rate 
(eGFR) and its presence predicts future decline in renal function.58, 59 Analysis of ~1000 
patients from Chronic Renal Insufficiency Cohort wih serial fundus photographs found that 
progressive retinopathy also tracks CKD progression in a subgroup of patients.60 However, 
these initial associations were lost after adjusting for baseline risk factors for progression 
suggesting little added benefit of retinal metrics.60 Both arteriolar narrowing and venular 
widening have been associated with prevalent CKD61 but whether retinal vessel calibres 
predict incident or progressive CKD is not clear (Table 2). The Atherosclerosis Risk in 
Communities study examined retinal photographs of ~10,000 middle-aged patients and 
showed that those in the lowest AVR quintile had the greatest increase in serum creatinine 
over a six-year period; this held true after adjusting for baseline vascular risk factors.59 
Analysis of retinal images from ~4,500 patients without baseline CKD from the Multi-Ethnic 
Study of Atherosclerosis study found that narrower arterioles predicted the development of 
CKD in white patients alone.65 However, other large, well designed studies have fil d to 
find an independent association between any vascular a ibre metric and CKD progression.61, 
64 
 
Albuminuria, an established marker of renal microvascular injury and an independent risk 
factor for CKD progression and incident CVD,1 may better reflect retinal vascular changes. 
Cross-sectional studies have shown that a narrower CRAE is independently associated with 
greater albuminuria71 and more severe glomerulopathy on histology in early diabetic CKD,72 
linking retinal and renal microvascular pathology. Additionally, baseline and subsequent 
arteriolar narrowing predicts worsening albuminuria and histological disease progression as 
well as decline in eGFR in both diabetic and non-diabetic CKD.62, 66, 72 Importantly, using 
CRAE in conjunction with albuminuria allowed better stratification of individuals at 
increased risk of CKD progression than albuminuria alone.66 
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Studies exploring fractals in CKD are few and conflicting. A small study from Singapore 
(n=260) found a modest U-shaped relationship between Df and CKD, suggesting that 
increased vascular branching complexity, potentially due to neovascularisation as is often 
seen in diabetic retinopathy, is also indicative of increased risk.73 A larger Malay study 
(n=3280) subsequently found lower Df to be strongly associated with lower eGFR and 
heavier proteinuria.74 In contrast, large studies of both diabetics and non-diabetics found no 
relationship between either baseline or change in Df and the presence or progression of CKD 
(Table 2)70, 75 
 
The lack of a consistent retinal vascular metric for the detection of incident and prevalent 
CKD may reflect the heterogeneity of the study populations, underlying aetiologies, 
metabolic abnormalities and treatments, such as immunosuppression and erythropoietin-
stimulating agents. It may also suggest that retinal photography has limited sensitivity to 
reveal a reliable metric amongst these competing influe ces.  
 
CVD outcomes 
Retinal arteriolar narrowing, in contrast to venular widening, shows greater associations with 
atherothrombotic rather than metabolic CVD risk factors,53 but both link to CVD outcomes. 
Large epidemiological studies and meta-analyses have shown that retinopathy, narrower 
arterioles and wider venules are common in patients with known ischaemic stroke disease.76-
78 Moreover, their presence predicts incident ischaemic stroke and stroke mortality, 
independent of other baseline CVD risk factors (Supplementary table 3).79-81 These same 
metrics are also independent predictors of atherosclerotic coronary artery disease morbidity 
and mortality, which appear stronger for women than men (Supplementary table 3).82, 83 A 
lower Df showed a linear relationship with worsening severity of coronary vessel stenosis in 
 12
~1,700 patients with ischaemic heart disease84 and also associated with prevalent stroke.85 In 
large prospective studies, a suboptimal Df conferred a 40% increased risk of stroke over a 5 
year period86 and a 50% increased risk of death from coronary artery disease over a 14-year 
period (Supplementary table 3).87 These analyses included adjustment for standard CVD 
risk factors and retinal vessel calibres suggesting a better predictive ability of Df.87 
 
The presence of retinal microvascular disease may also stratify patients at future risk of CVD 
as demonstrated by a recent study of >3,500 patients with microalbuminuria. Here, a wider 
CRVE predicted incident CVD over six years.88 Furthermore, the presence of a single retinal 
microvascular abnormality, in conjunction with microalbuminuria, increased the risk of 
incident CVD 2-fold, and this rose to >6-fold if multiple vascular abnormalities were 
present.88 Finally, and importantly, the use of retinal vascular metrics such as arteriolar 
narrowing and venular widening can provide added benefit over current atherosclerotic CVD 
risk prediction tools as demonstrated for ischaemic stroke81 and coronary artery disease.89 
 
These data provide robust evidence of the potential clinical utility of retinal imaging-based 
CVD risk assessment. Transition into clinical practice is still awaited and may have been 
hindered by inherent limitations (Table 1). The use of novel imaging modalities to target 
deeper vascular networks such as the choroidal circulation, which may reflect microvascular 
disease earlier and more accurately, might overcome some of these challenges. This is now 
possible through retinal optical coherence tomography (OCT). 
 
Retinal OCT 
Retinal OCT provides high-resolution, tomographic (cross-sectional) imaging of the eye with 
near histological detail.90 The advent of retinal OCT has transformed clinical ophthalmology. 
In 2010, an estimated 16 million OCT scans were performed in the United States alone, more 
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than all other ocular imaging combined.91 This rapid expansion has provided novel insights 
into the role of the chorioretinal microvasculature in the pathogenesis of age-related macular 
degeneration, diabetic retinopathy and glaucoma, eye diseases that have an increased 
prevalence in CKD.61 The technical principles underpinning OCT are analogous to those of 
ultrasound but measure light reflections rather than t e sound echoes (Supplementary figure 
3). The measurement of small variations (interference) in light waves over short distances is 
made possible through the use of interferometry. In current generations of OCT, a Fourier 
transform analyses multiple interference signals simultaneously via a spectrometer (spectral 
domain OCT) or a tuneable laser (swept source OCT) resulting in extremely fast image 
acquisition.90 Swept source OCT may also provide better tissue penetration than spectral 
domain OCT allowing better identification of deep structures like the choroid.92 
 
The ultra-high resolution (typically 2-8µm) of OCT allows identification and automated 
segmentation of retinal layers providing measures of gl bal and regional retinal thickness, 
volume and nerve fibre layer thickness allowing detection of retinal neurodegeneration. 
(Table 3, Figure 4, Supplementary figure 4, videos 1 & 2).90 Importantly, OCT devices are 
capable of eye-tracking and image co-registration for accurate longitudinal imaging. Another 
key strength of OCT is the potential to image the pr viously inaccessible choroid, which is 
almost entirely composed of the blood vessels of the choroidal circulation (Figure 4). OCT-
derived metrics of choroidal structure have been shown to be reproducible, correlate well 
with histology and may be surrogate measures for microvascular density with thinning 
suggestive of rarefaction.93-95 In addition, the cross-sectional nature of the OCT image allows 
vessel wall/lumen analyses. OCT devices can also acquire en-face retinal images for vessel 
calibre assessment to complement choroidal imaging (Supplementary figure 2).96 In short, 
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OCT allows comprehensive structural assessment of the entire chorioretinal circulation and 
its dependent tissue in vivo within a single platform. 
 
The chorioretinal circulation: CVD risk factors and outcomes  
Hypertension  
We have used OCT to prospectively examine chorioretinal thickness in patients with 
established hypertension and age- and sex-matched healthy subjects.97 We excluded patients 
with a history of eye disease, diabetes, or overt CVD. We found no differences in OCT 
metrics between these carefully matched groups. Two larger studies have produced 
contrasting results. The Beijing Eye study imaged ~3,000 adults and reported small increases 
in choroidal thickness with increasing diastolic BPbut not systolic BP.98 Paradoxically, the 
presence of hypertension was characterised by choroidal thinning. A subsequent cross-
sectional study from Korea found that patients with hypertension (n=140) had significant 
retinal thinning in nearly all regions assessed compared to those without hypertension 
(n=687).99 Notably the hypertensive group was older with a greater prevalence of CVD risk 
factors. More recently, a single centre study from Italy of 100 patients with hypertension 
found consistent retinal and choroidal thinning in hypertensives with co-existent CKD 
(defined by an eGFR <60 ml/min/1.73m2 and/or moderate albuminuria) compared to 
hypertensives with preserved renal function.100 These differences persisted following 
adjustments for age, antihypertensive use and glycaemia. The lack of a matched healthy 
control group in this otherwise well-designed study limits wider generalisability to CVD risk. 
 
OCT also enables cross-sectional assessment of retinal vessels. Muraoka et al reported a 
greater arteriolar and venular wall thickness in 106 hypertensive patients compared to 132 
patients without hypertension.101 Given lumen size remained normal, their findings suggested 
outward vascular remodeling.  
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Interpreting the broader significance of these contrasting results in hypertension is difficult as 
different ethnic groups were studied, imaging devics varied, medication and comorbidity 
data were inconsistently reported, and those with diabetes were variably included. Large 
prospective studies that take such factors into accunt are needed to clarify any relationship 
and explore causality. 
 
Diabetes mellitus 
Studies using OCT to assess retinal thickness between patients with and without diabetes 
overall have shown significant thinning of the nerve fibre and ganglion cell layers even when 
retinopathy is absent or mild.102, 103 104 Retinal ganglion cells are interneurons that transmit 
visual information from photoreceptor cells to the visual cortex via the optic nerve. Ganglion 
cell apoptosis is an early hallmark of retinal neurodegeneration which manifests as thinning 
of the ganglion cell layer (GCL) on OCT.105 Such GCL thinning is not observable by 
standard retinal photography or scanning laser ophthalmoscopy.105 Studies using OCT in 
types 1 and 2 diabetes, with no or minimal clinically observable retinopathy, have found 
selective GCL thinning compared to health.102, 103 The degree of thinning correlates highly 
with duration of type 1 diabetes.102 Studies of the choroid also show that patients with 
diabetes have thinner choroids compared to age- and sex-matched controls, even in the 
absence of retinopathy.106, 107 Recent work suggests that greater reductions in choroidal 
thickness and choroidal vascular density occur with orsening retinopathy in keeping with 
progressive microvascular damage.108 Whether the choroidal thinning contributes to, or 
indeed is a result of, retinal vascular disease needs further study. The choroid may therefore 
reflect early systemic vascular changes in diabetes such as glomerular hyperfiltration and 
hypertension. 
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Pre-dialysis CKD 
We showed, for the first time, that patients with varying degrees of non-diabetic, pre-dialysis 
CKD exhibit ~5% retinal and ~25% choroidal thinning compared to both age- and sex-
matched healthy subjects and patients with hypertension (Figure 4).97 The highly vascular 
nature of the choroid suggests that thinning here is likely to represent changes in 
microvascular structure or function. Supporting this, we found that the choroid was thinner in 
those with a lower eGFR and greater proteinuria, both strongly associated with microvascular 
dysfunction.109, 110 Also, those with a thinner choroid had higher circulating ET-1 and plasma 
asymmetric dimethylarginine (an endogenous inhibitor of nitric oxide synthesis) further 
supporting this association. Importantly, we linked chorioretinal thinning with renal 
histology, showing that the severity of glomerular injury reflected the degree of choroidal 
thinning. Recent data using different OCT platforms have confirmed our results. The 
previously discussed Italian study found that lower eGFR and greater microalbuminuria were 
associated with choroidal thinning using swept source OCT in 100 hypertensive patients.100 
Moreover, with respect to eGFR, this association was independent of age and other vascular 
risk factors.100 These results are interesting as eGFR was preserved (~70 ml/min/1.73m2) and 
proteinuria was low suggesting only modest microvascular damage. This contrasts with our 
work where CKD patients had moderate-to-severe renal disease (mean eGFR ~37 
ml/min/1.73m2, proteinuria equivalent to ~2 g/day).97 Another recent study included patients 
with more advanced CKD and found a consistent relationship between lower eGFR, greater 
protein leak and a thinner choroid.111 The differences in OCT metrics between CKD, 
hypertension and health, as well as their associations with CKD severity, provide initial 
evidence for the potential of OCT to identify and stratify individuals at increased CVD risk. 
Whether these metrics reflect systemic microvascular damage better than standard tools 
should be tested in future studies. Finally, the consistency of these findings across different 
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OCT devices using different technology and segmentatio  algorithms at least supports the 
fidelity of the relationship. Studies exploring whet r this relationship can predict CKD 
outcomes are awaited.  
 
ESRD 
CVD risk is greatest in those with ESRD and on maintenance dialysis.1 Haemodialysis is 
associated with repetitive subclinical myocardial injury, which has been linked to 
microvascular dysfunction that likely contributes to this risk.112 A simple, non-invasive 
method of assessing microvascular disease in this very high-risk group would be useful. In 
keeping with our data, studies have shown that dialysis patients have global retinal thinning 
compared to healthy controls.113 Additionally, a few small clinical studies in these patients 
have assessed how OCT metrics may be influenced by dialysis per se (Table 4). Collectively 
these studies suggest that the choroid, and the retina to a lesser extent, thins following 
dialysis with the greatest reductions seen patients with diabetic retinopathy. Whether thinning 
occurs because of changes in BP (altering chorioretinal perfusion), solute clearance, fluid 
removal or change in intraocular pressure is unclear and the studied cohorts are probably too 
small and/or heterogenous to assess these relationships in detail. Retinal nerve fibre layer 
thinning has been associated with neurodegenerative disease such as Alzheimer’s disease and 
Parkinson’s disease,126 suggesting OCT can act as a window to the brain and cognition. 
Similar thinning has been found in haemodialysis patients125 and supports recent data linking 
intradialytic cerebral hypoperfusion to progressive cognitive impairment.127 There are no 
robust OCT studies in renal transplant recipients, but the available data suggest retinopathy 
and nerve fibre layer thinning are common.128 
 
CVD outcomes 
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Studies linking OCT-derived metrics to prevalent CVD are beginning to emerge. Altinkaynak 
et al, studied 56 patients with heart failure with a reduced ejection fraction and found 
choroidal thinning of ~30% compared to age- and sex-matched healthy controls.129 A thinner 
choroid was strongly associated with a worse ejection fraction in unadjusted analyses, which 
may reflect choroidal vasoconstriction secondary to reduced cardiac output.129 No data on 
possible confounders such as renal function, diabetic status, CVD risk factors and 
concomitant drugs were reported. 
 
Choroidal but not retinal thinning has been shown in patients with established coronary artery 
disease (defined by angiographic coronary artery stenosis, a positive stress test and/or 
previous coronary revascularisation or myocardial infarction) compared to health in small 
studies.130, 131 However, limited reporting on possible confounding CVD risk factors, the 
inclusion patients with diabetes and a high CVD risk control group weaken these 
associations.130, 131 A recent study using spectral domain OCT, examined a subgroup of 764 
elderly patients (mean age 82 years, two-thirds femal ) from a French population-based study 
(>9,000 participants) and found no associations betwe n subfoveal choroidal thickness and 
previous CVD, current CVD risk factors or estimated future CVD risk according to a clinical 
scoring tool.132 A large amount of missing data, recall bias from patient-declared medical 
history and a single manual measure of choroidal thickness may have contributed to these 
negative results.  
 
There are no data linking OCT-metrics to incident CVD to extend the relevance of the 
associations presented. These data are likely to appear soon and whether OCT-derived 
metrics can outperform photography-derived metrics for the prediction of CKD and CVD 
outcomes is an important test of their potential utility. An additional area that warrants 
exploration is the extent to which retinal OCT metrics are modifiable by interventions such as 
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lowering BP, reducing proteinuria or restoring kidney function. Such data might allow OCT-
derived metrics to be developed from biomarkers into easily assessable surrogate endpoints 
for clinical trials. 
 
OCT angiography (OCT-A) 
Retinal OCT-A combines structural and functional imaging by analysing the changing 
variance in light speckle created by erythrocyte flow over multiple scans. This generates a 
contrast-free angiogram down to the capillary level and surrogate indices of perfusion 
(Figure 5).90 Most OCT-A platforms have integrated software that au omatically segments 
the OCT images alongside angiographic data to report gl bal and regional vessel density for 
each retinal layer (Supplementary figure 5; Supplementary videos 3 & 4). OCT-A images 
can be also be used to assess Df and the geometry of the foveal avascular zone (FAZ) with 
widening indicative of capillary drop out (Figure 5). Visualisation of these terminal branches 
of the vascular tree may allow earlier, more precise detection of local and systemic 
microvascular disease. Small clinical studies of age-related macular degeneration133 and 
diabetic retinopathy134 have used OCT-A to demonstrate novel structural vessel pathology 
with an apparent reduction in perfusion. Limitations of OCT-A include a susceptibility to 
movement artefact degradation and a lack of true perfusion indices. Doppler OCT, which 
detects the frequency shift of back-scattered light from erythrocytes allowing determination 
of blood flow velocity alongside vessel dimensions, may overcome this latter issue.90 
 
Hypertension, diabetes mellitus and CKD 
Data supporting a potential role for OCT-A in systemic diseases are emerging. A study of 
Asian patients with hypertension found that those with poor BP control (assessed by 24h 
ambulatory monitoring) had a lower deep capillary plexus vessel density compared to those 
with optimal BP control.111 These groups were well matched in terms of age, sex, CVD risk 
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factors and renal function (mean eGFR ~90 ml/min/1.73m2) but the poorly controlled group 
had greater microalbuminuria.111 In adjusted analyses suboptimal BP control, increasing BP 
and worsening eGFR were associated with worse capillary rarefaction.111 An Italian study 
extended these findings by using OCT-A in 120 hypertensive patients with and without CKD, 
to report a lower vessel density in both superficial and deep capillary plexuses in those with 
CKD.135 The inclusion of patients with more severe renal impairment and heavier proteinuria 
in this study135 may explain the more extensive retinal vessel rarefaction seen compared to 
the Singapore study.111 However,  it is important to note different OCT-A devices were used 
by each centre.  
 
In diabetes, greater FAZ area, lower retinal capillry density and reduced Df have been 
shown to predict progression of diabetic retinopathy.136 A recent study using OCT-A has 
suggested a potential vascular basis for GCL thinning in diabetes.137 Patients with no 
detectable retinopathy, with a short duration of diabetes (~8 years) and normal renal function, 
had significant GCL thinning that was independently associated with lower retinal capillary 
density and perfusion, suggesting a structural or functional vascular origin.137 This hypothesis 
is countered by pre-clinical and clinical data suggesting that GCL thinning can occur without 
alterations in histologically-assessed capillary density.138 In summary, GCL thinning appears 
early in diabetes, potentially prior to structural vascular changes but convincingly before 
overt target organ damage. The earliest functional changes in the diabetic kidney are 
glomerular hyperfiltration and hypertension.139 and detecting this would be useful in guiding 
intervention and treatment efficacy. Whether GCL thinning or changes in GCL perfusion can 
act as an early marker of tissue dysfunction in diabetes such as glomerular hyperfiltration and 
hypertension warrants detailed further study. There are few data in diabetic CKD but a recent 
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study using OCT-A in 184 patients with type 2 diabetes suggested that a reduced retinal 
capillary density independently predicted co-existing CKD and its severity.140  
 
Given the association with risk factors for CKD progression, data linking OCT-A to long 
term renal outcomes should soon emerge. However, idntifying patients at risk of acute 
kidney injury (AKI) is also important as AKI confers an increased risk of future CKD141 and 
CVD.142 OCT-A-derived retinal vessel density was recently shown to predict the risk of 
contrast-induced AKI following angiography for acute coronary syndrome.143 Moreover, the 
addition of OCT-A metrics to current contrast-induced AKI risk assessment tools improved 
prediction of AKI by ~10%.143 
 
CVD outcomes 
As with OCT, data linking OCT-A metrics to incident CVD are lacking. With respect to 
prevalent CVD, a study of 246 patients presenting with an acute coronary syndrome found 
that these patients had reduced inner retinal vessel density compared to a limited number of 
age- and sex-matched controls.144 In addition, more severe rarefaction correlated with a 
greater CVD risk as defined by the American Heart Association and Global Registry for 
Acute Coronary Events scoring systems.144  
 
Dynamic functional imaging  
Laser doppler flowmetry and flicker response imaging can assess retinal vascular endothelial 
function in a dynamic manner. Studies examining laser flicker-induced vascular responses 
have shown impaired retinal endothelium-dependent vasodilatation in patients with CVD risk 
factors including albuminuria,145 pre-diabetes,146 early hypertension,147 pre-eclampsia148 and 
hypercholesterolaemia.149 In addition, a recent study reported worsening retinal endothelial 
function (as measured by the degree of laser flicker-induced vasodilatation) between health, 
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those at risk of CVD and those with overt CVD,150 supporting the potential to stratify 
patients. Limitations of these techniques include th  need for mydriasis, longer acquisition 
time compared to other imaging techniques and assessment of retinal vessels alone.  
 
Visions for the future 
Pre-clinical OCT 
Pre-clinical OCT allows simultaneous non-invasive longitudinal imaging of the eye in 
disease models and may provide novel insights into u derlying mechanisms. We have used 
OCT to explore the links between the eye and kidney and shown that mice with hypertension 
alone had no choroidal thinning whereas mice with matched hypertension but with coexisting 
renal injury developed significant thinning.97 This technology is being refined but has been 
used to perform detailed structural, functional and biochemical assessments in various 
models of retinopathy.151 
 
Big data 
The recognition of the potential power of OCT beyond eye disease is evidenced by its 
inclusion in the United Kingdom Biobank study between 2006 and 2010.152 UK Biobank  
obtained OCT images from >67,000 participants (of whom >35,000 were healthy) along with 
socio-demographic, cognitive, CVD and renal risk measures. This could provide novel, 
robust epidemiological data to establish healthy ranges and generate evidence of OCT 
metrics as prognostic disease biomarkers. The expansion of OCT out of hospital settings and 
into the community is already in progress with the leading optometry chain in the United 
Kingdom announcing a roll out of OCT devices across all outlets.153  
 
Deep learning 
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Machine learning involves programming computers to detect patterns in raw data, based on 
explicit parameters set by the operator. Such techniques have been utilised to automate 
classification of diabetic retinopathy from fundus photographs but can be intensive to 
engineer and supervise. Deep learning is an extension of machine learning whereby 
predictive patterns are learnt and refined by the machine itself, using an algorithm developed 
from a large example dataset such as a bank of graded retinal images.154 Multiple levels of 
increasingly abstract pattern recognition enable the algorithm to develop complex neural 
networks that are highly accurate, require minimal engineering and can match expert human 
performance as shown recently with diabetic retinopathy.155  
 
Recent work in this field has used retinal photographs and clinical data from >280,000 
patients to train an algorithm to predict a range of CVD risk factors from two separate banks 
of retinal photographs totalling ~13,000 patients.156 The algorithm displayed impressive 
accuracy: gender (AUC 0.97), smoking status (AUC 0.71), age (mean absolute error ~3 
years) and systolic BP (mean absolute error ~11 mmHg).156 For predicting incident CVD 
risk, the algorithm offered little improvement over a conventional CVD risk-scoring tool but 
encouragingly showed similar power. More recently, one of the authors of this review (PAK), 
co-led the development of a deep learning algorithm at allows triage and diagnosis of the 
commonest sight-threatening retinal diseases from OCT scans.157 On a large retrospective 
dataset, this algorithm demonstrated diagnostic accur y equivalent to that of specialist 
ophthalmologists. Prospective clinical trials of this algorithm are now planned. Importantly, 
the algorithm also creates an intermediate representatio  of the retinal anatomy/pathology 
and thus addresses, in part, the concerns raised by clinicians regarding artificial intelligence 
systems which can be often perceived as ‘black boxes’ dictating clinical care. This approach 
will likely be readily transferable from ophthalmic to systemic disease, offering novel 
insights and generating new hypotheses. 
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Challenges 
The real-world utility of the retinal vascular metrics for CVD risk profiling over currently 
available tools is uncertain. Well-designed studies show that such metrics can offer a small 
benefit (~10%) over current tools in identifying hig -risk patients.66, 81, 89 Whether this is 
sufficient for integration into clinical practice is not known nor is how best to act on them. 
The high fidelity and granular nature of OCT data my yield novel metrics that extend risk 
stratification beyond what retinal photography has achieved. Pre-clinical and clinical studies 
with longitudinal imaging and data-linkage, currently available in only a few countries, will 
be required to confirm this. However, the highly competitive commercial interest in retinal 
OCT has led to emergence of several devices each with un que retinal layer segmentation 
algorithms and so metrics are not interchangeable across devices.158, 159 Finally, maximising 
the yield of data from complex OCT and OCT-A images will require similar advancement 
and investment in imaging analysis methodology which, given the advent of artificial 
intelligence in healthcare, is an exciting field in itself. 
 
Conclusions 
The eye offers a well-defined target organ whose microvessel network is homologous to that 
in kidney in both health and disease. The chorioretinal microvasculature can now be precisely 
mapped, measured and tracked. Quantitative vessel analysis of retinal photographs has 
provided a strong rationale for the eye to report and stratify CVD risk but this is yet to 
transition into clinical practice. Novel modalities such as OCT have undergone rapid clinical 
expansion and have shown potential in detecting microvascular changes that are associated 
with surrogate markers of increased renal and CVD risk. Advances in data analysis and 
machine learning may soon enable clinicians to generate individualised chorioretinal risk 
scores to identify patients at risk of adverse outcmes based on precise, segmented OCT 
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metrics. The advancement of multimodal functional retinal imaging has brought the 
previously distant goal of non-invasive functional microvascular assessment into sharp focus 
and the near term. 
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Table legends 
 
Table 1. Retinal vascular metrics from retinal photography 
 
Table 2. Retinal vascular metrics to predict incident or prog essive chronic kidney disease 
BP – blood pressure, AVR – arteriole-to-venule ratio, OR – odds ratio, CRAE – central 
retinal arteriolar equivalents, CRVE – central retinal venular equivalents, RR – risk ratio, IFG 
– impaired fasting glucose, HR – hazard ratio, eGFR – estimated glomerular filtration rate, 
CKD – chronic kidney disease, Df - fractal dimension, ESRD – end stage renal disease. All 
values are mean. 
 
Table 3. Chortioretinal layer metrics from optical coherence tomography 
 
Table 4. Haemodialysis and OCT metrics. Studies examining OCT metrics before and after a 
haemodialysis session in patients on long-term renal r placement therapy. ↑ denotes increase, 
↓ denotes decrease. UF – achieved ultrafiltration volume, BP – blood pressure, IOP – 
intraocular pressure, RNFL – retinal nerve fibre layer, EDI – enhanced depth imaging, L – 
litres, SBP – systolic blood pressure, DBP – diastolic blood pressure. All values are mean. 
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Table 1.
Metric Derivation Interpretation Strengths Weaknesses 
 
Central retinal arteriolar 
equivalents (CRAE) 
 
Widths of reflective erythrocyte column within 
vessel lumen from six largest arterioles located in 
a zone 0.5-1 disc diameters from optic disc 
margin 
 
Summarised surrogate measure of 
internal arteriolar widths that reflect 
narrowing or widening 
 
Provides insight into disease 
affecting arterioles 
 
Relatively easy to obtain and 
automate 
 
  
 
Summarised rather than absolute 
values 
 
Potential for magnification and 
positioning errors 
 
Values are not true vessel widths nor 
cross-sectional area which may be 
more relevant to disease 
 
 
Central retinal venular 
equivalents (CRVE) 
 
Widths of reflective erythrocyte column within 
vessel lumen from six largest venules located in a 
zone 0.5-1 disc diameters from optic disc margin 
 
Summarised surrogate measure of 
internal venular width that reflect 
narrowing or widening 
 
Provides insight into disease 
affecting venules 
 
Relatively easy to obtain and 
automate 
 
 
Summarised rather than absolute 
values 
 
Potential for magnification and 
positioning errors 
 
Values not true vessel widths nor 
cross-sectional area which may be 
more relevant to disease 
 
 
Arteriole-to-venule ratio 
(AVR) 
 
Ratio of CRAE to CVRE 
 
Changes usually indicative of 
generalised arteriolar narrowing  
 
Avoids magnification errors 
 
Dimensionless 
 
Provides little insight to underlying 
pathophysiology 
 
If used alone, can lead to incorrect 
inferences: both CRVE and CRAE 
narrow with increasing BP producing a 
normal AVR masking any association. 
 
 
Fractal dimensions (Df) 
 
Images are binarised and vessel maps are 
broken up into short segments (‘skeletonisation’).  
 
Entire image divided into boxes and those 
containing a vessel segment are counted. 
Process is repeated with different box sizes. The 
number of boxes with vessel segments is plotted 
against the total number of boxes in the image. 
 
Index of vessel network spatial 
occupancy (complexity). 
 
Reduced (sparse) or increased 
(dense) complexity relative to health 
or within a cohort reflect suboptimal 
vascular network geometry. 
 
Based on robust models of 
optimality of vascular branching  
 
May be more sensitive than 
calibres in reflecting microvascular 
disease in other organs beds 
 
Less widely studied than calibres 
 
Simplifies 3-dimensional vascular 
networks into 2-dimensional 
skeletonised maps 
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Table 2. 
Study Country n 
Population 
Mean age 
Retinal 
metric 
Clinical outcome Hypertension Mean BP Diabetes 
Index serum 
creatinine or 
eGFR 
Follow 
up 
Results 
            
Wong
59
 
2004 
 
Prospective, 
Population -
based cohort 
US 10,056 White and 
African-
American 
adults, eGFR  
>60mls/min 
 
60 years 
AVR Incident renal 
dysfunction: rise in 
serum creatinine by 
≥35µmol/L or hospital 
admission/death coded 
for renal disease 
50% 127/70 mmHg 22% 80µmol/L 6 years 3% developed CKD 
 
Smallest AVR associated with greater 
change in serum creatinine (4 vs 
2µmol/L) 
            
Wong
62
 
2004 
 
Prospective, 
Population -
based cohort 
US 557 Type 1 diabetics 
eGFR 
>90mls/min, 
proteinuria 
<0.3g/L 
 
31 years 
CRAE 
CRVE 
Incident renal 
insufficiency: eGFR 
<60mls/min 
 
Incident gross 
proteinuria: >0.3g/L 
No data 120/76 mmHg 100% No data 16 years 20% developed CKD 
33% developed proteinuria 
 
Widest CRVE quartile associated with 
increased incidence of CKD and 
proteinuria 
CKD: adjusted RR 1.5(1.05-2.2) 
Proteinuria: adjusted RR 1.5(1.2-2) 
 
No association for CRAE 
            
Edwards
63
 
2004 
 
Prospective, 
Population -
based cohort 
US 1,394 Adults aged >65 
years 
 
78 years 
AVR Change in serum 
creatinine 
 
Decline in renal 
function: increase in 
serum creatinine by 
≥27µmol/L and fall in 
eGFR by ≥20% 
 
 
57% 131/67 mmHg 17% 89µmol/L 
 
70mls/min 
4 years 4-5% developed a significant increase in 
serum creatine or fall in eGFR 
 
AVR showed no associations with 
changes in renal function 
 
Retinopathy associated with greater 
risk of decline in renal function: 
Adjusted OR 2.8-3.2 vs. no retinopathy 
            
Sabanayagam
64
 
2011 
 
Prospective, 
Population -
based cohort 
US 3,199 
 
White adults 
with eGFR 
>60mls/min 
 
59 years 
 
 
CRAE 
CRVE 
Incident CKD: eGFR 
<60mls/min and 25% 
decrease from baseline 
 
 
 
45% 130/78 mmHg 
 
 
9% 85mls/min 15 years 5% developed CKD 
 
No association CRAE or CRVE with 
incident CKD 
 
No association with eGFR and incident 
CRAE narrowing or CRVE widening 
            
Yau
65
 
2011 
US 4,594 Multi-ethnic 
adults, eGFR 
CRAE 
CRVE 
Incident CKD: eGFR 
<60mls/min 
40% 127/71 mmHg 11% 76mls/min 4.8 years 5% developed CKD 
 
 46
 
Prospective, 
Population -
based cohort 
>60mls/min 
 
64 years 
Narrowest CRAE tertile associated with 
incident CKD in white patients only: 
adjusted HR 1.78 (1.01-3.1) vs. widest; 
increased to 2.95 when analysing those 
without hypertension or diabetes 
 
No association with CRVE 
            
Baumann
66
 
2014 
 
Prospective 
 
Germany 141 Adults, CKD 
stage 2-4 
 
61 years 
CRAE Progression of CKD: 
50% decline in eGFR or 
start of RRT 
 
No data 137/76 mmHg 46% 48mls/min 3.9 years 17% had progression in CKD 
 
Narrowest CRAE tertile associated with 
progression in CKD: adjusted OR 3 (1.2-
7.5) vs. widest CRAE 
 
Narrowest CRAE in presence of 
albuminuria associated with 10-fold 
increased risk of CKD progression, 
compared to 3-fold risk seen with 
narrow CRAE or albuminuria alone 
            
Grunwald
67
 
2014 
 
Prospective, 
Population -
based cohort 
US 1852 Adults, eGFR 20-
70mls/min 
 
62 years 
AVR 
CRAE 
CRVE 
Progression in CKD: 
ESRD/RRT, 
Change in eGFR slope 
 
 
 
90% 130/80 mmHg 47% 40mls/min 2.3 years 8% developed ESRD 
eGFR decline 0.53ml/min 
 
Greater AVR associated with ESRD and 
steeper eGFR decline: adjusted HR 3.1 
(1.5-6.4). 
 
No associations with CRAE and CRVE 
            
Yip
68
 
2015 
 
Prospective, 
Population -
based cohort 
Singapore 5763 Malay adults 
 
55 years 
AVR 
CRAE 
CRVE 
Df 
 
Incident ESRD: defined 
by start of renal 
replacement therapy 
55% 140/70 mmHg 34% 77mls/min 4.3 years 0.4% developed ESRD 
 
No associations for vascular metrics and 
risk of ESRD in adjusted analyses 
 
Retinopathy predicted ESRD. 
            
Yip
69
 
2017 
 
Prospective, 
Population -
based cohort 
Singapore 1256 
 
 
Malay adults 
 
56 years 
CRAE 
CRVE 
Tortuosity 
Df 
Branching 
angles 
 
Incident CKD: eGFR 
<60mls/min 
58% 150/80 mmHg 25% 80mls/min 6 years 6% developed incident CKD 
 
Narrower CRAE associated with 
incident CKD: adjusted HR 1.3 (1-1.78) 
as continuous variable. 
 
Widest CRVE tertile associated with 
incident CKD: adjusted HR 2.4 (1.1-5.9) 
vs. narrowest 
 
No other vascular metrics associated 
with incident CKD 
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McKay
70
 
2018 
 
Prospective, 
Population -
based cohort 
Scotland 1068 Adults eGFR 
≥60mls/min 
 
63 years 
CRAE 
CRVE 
Tortuosity 
Df 
Branching 
angles 
 
Change in eGFR: 
‘Progressors’: eGFR 
<60mls or ≥15% decline  
 
‘Non-progressors’: 
<10% decline 
No data 138/77 mmHg 100% 94mls/min 3 years 31% had ‘progressive’ CKD 
 
No baseline retinal metric predicted 
progression of CKD in unadjusted or 
adjusted analyses. 
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Table 3. 
Metric  Derivation  Interpretation  Strengths  Weaknesses 
 
Retinal thickness 
  
Calculated from the number of A-scan pixels 
between the internal limiting and Bruch’s 
membranes. 
 
Sequential A-scans in horizontal or vertical 
plane generate a two-dimensional thickness 
profile across the retina, the B-scan 
 
  
Average thickness of peripheral and central 
retinal subfields 
 
Thinning predominantly reflects neuronal loss. 
May also reflect intra-retinal capillary rarefaction 
 
Thickening reflects accumulation of oedema, 
vascular exudates or cellular debris 
  
Can allow detection of differential patterns of 
retinopathy: global thinning vs. 
predominantly central or peripheral subfield 
thinning 
 
Easy to obtain, automated and highly 
reproducible 
 
Segmentation of retinal sublayers can 
provide novel insight into pathogenesis such 
ganglion cell layer 
  
Layer and subfield boundaries not 
standardised across devices 
 
Overall thickness may miss sublayer 
thinning or thickening 
 
Cannot differentiate between 
neuronal or vascular structures 
 
 
 
Macular volume 
  
Calculated as product of retinal thickness and 
scan area. The scan area can be subdivided 
into the Early Treatment of Retinopathy in 
Diabetes Study (ETRDS) map of 6mm, 3mm 
and 1mm concentric rings centred on the fovea, 
producing 9 subfields 
  
Global and regional volumes of key region for 
vision 
 
Thinning predominantly reflects neuronal loss. 
May also reflect intra-retinal capillary 
rarefaction. 
 
Thickening reflects accumulation of oedema, 
vascular exudates or cellular debris 
  
Can allow early detection and tracking of 
differential patterns of maculopathy 
 
Segmentation of sublayers can provide novel 
insight into pathogenesis 
  
Easy to obtain, automated and highly 
reproducible 
  
Accuracy dependent on total number 
of stacked horizontal B-scans within 
scan area 
 
Layer boundaries and B-scan 
protocols not standardised across 
devices 
 
 
Retinal nerve fibre 
layer thickness 
  
Calculated from the number of A-scan pixels 
between the internal limiting membrane and 
ganglion cell layer 
 
Sequential A-scans in horizontal, vertical plane 
or circular plane centred on the optic disc 
generate a thickness profile 
 
  
Global and regional assessment of ganglion cell 
(GC) axon number 
 
Thinning reflects GC axonal loss 
 
Thickening reflects axonal oedema seen in 
inflammation, ischaemia or intracranial 
hypertension 
  
Specific biomarker of optic neuropathy and 
wider central neurological disease 
 
Allows earlier detection and tracking of 
differential patterns of neuropathy. 
 
Easy to obtain, automated and highly 
reproducible 
 
Standardized normative range available for 
glaucoma and neurological disease 
  
Blood vessels (and glial cells) within 
RNFL are included in measurement 
so not truly representative of GC 
axon population 
 
Segmentation errors can occur 
 
Susceptible to confounding by optical 
biometrics such as axial length, disc 
size, disc-fovea angle 
 
Choroidal thickness 
  
No precise definition or standard methodology. 
Calculated from the number of A-scan pixels 
from Bruch’s membrane to choroidoscleral 
interface. 
  
Often manually measured at several discrete 
locations  
 
Newer devices provide automatic segmentation 
to automatically calculate regional choroidal 
thickness and volume in a manner similar to 
that for retinal thickness and volume. 
  
Coarse measure of a dense vascular layer 
containing arterioles, capillaries, venules and 
veins. 
 
Thinning reflects vascular changes including 
reduced blood flow, vasoconstriction or 
rarefaction. Contribution of non-vascular 
components unclear. 
 
Thickening may due to increased blood flow, 
vasodilatation or oedema. Contribution of non-
vascular components unclear. 
  
Easy to obtain, increasingly automated and 
reproducible 
 
Assess critical vascular supply to retina and 
reveals new insight into macular disease 
  
Inaccessible location continues to 
limit comprehensive vascular 
assessment 
 
Does not differentiate between 
vascular and non-vascular structures  
 
Susceptible to confounding by optical 
biometrics such as axial length 
 
No standardized normative range 
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Table 4. 
Author Year Country Device n Age Proportion with diabetes 
Dialysis 
vintage 
UF 
volume ∆ weight ∆ BP ∆ IOP 
∆ retinal 
thickness 
∆ choroidal 
thickness ∆ RNFL 
∆ vessel 
density 
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Shin114 2019 South Korea DRI Triton 32 56 years ~66% 6 years 3L ↓ 2.6kg ↓ SBP ~12mmHg No change - ↓ ~5% - - 
Shin115 2018 South 
Korea 
DRI OCT1  
Atlantis 
29 56 years ~52% 5.8 years 3L ↓ 2.7g ↓ SBP ~10mmHg No change No change ↓ ~7% - ↓ ~3% 
Zhang116 2018 China AngioVue 77 53 years ~50% 4.5 years 2.5L - ↓ SBP ~7mmHg No change ↓ ~2% No change - ↓ ~3% 
Chen117 2018 China Cirrus HD 90 58 years ~13% 5.8 years - - 
↓ SBP ~10mmHg 
↓ DBP ~7mmHg No change No change ↓ ~12% ↑ ~3% - 
Chang118 2017 South Korea 
Spectralis 
with EDI 54 60 years ~60% 5 years - ↓ 2.3kg 
↓ SBP ~15mmHg 
↓ DBP ~4mmHg ↓ ~10% - ↓ ~10% No change - 
Ishibazawa119 2015 Japan RetinaScan No EDI 77 67 years ~50% 4.7 years 2.5L ↓ 2.2kg 
↓ SBP ~14mmHg 
↓ DBP ~4mmHg No change No change ↓ ~10% - - 
Jung120 2014 South Korea 
Spectralis 
No EDI 19 51 years ~50% 3.5 years - ↓ 2.1kg ↓ SBP ~16mmHg No change - ↑ ~5% - - 
Yang121 2013 South Korea 
Spectralis 
with EDI 34 58 years ~25% 6 years - ↓ 2.8 kg No change ↓ ~10% No change ↓ ~6% No change - 
Ulas122 2013 Turkey Spectralis 
with EDI 
21 61 years - 2.4 years 3L - No change No change No change ↓ ~10% - - 
Jung123 2013 South Korea 
Spectralis 
No EDI 30 54 years ~40% 4.3 years - ↓ 1.9kg 
↓ SBP ~17mmHg 
↓ DBP ~7mmHg ↓ ~15% ↓ ~2% - - - 
Theodossiadis124 2011 Greece OCT3 Stratus 72 62 years 100% 2.8 years - ↓ 2.5kg No change - ↓ ~4% - - - 
Demir125 2008 Turkey OCT3 Stratus 36 41 years - 3.5 years - - - - - - No change - 
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Figure legends 
Figure 1. Initiation and consequences of microvascular diseas.5  
Light blue arrows show additional association/contribution between insults. Dark blue 
arrows indicate sequence of events leading to development and progression of end-organ 
dysfunction. GFR: glomerular filtration rate; SVD: small vessel disease; CAD: coronary 
artery disease; LVH: left ventricular hypertrophy. 
 
Figure 2. The eye as a window to the kidney  
The microcirculation of the eye is characterised by multiple capillary networks which, 
although arranged in close proximity, have striking structural and functional differences. This 
is also true of the renal microcirculation. 
A. Upper panel – cross-sectional diagram of glomerular capillary  
     Lower panel –  cortico-medullary microcirculation organisation, oxygen gradients and 
actions of renal-angiotensin-aldosterone and endothelin systems 
B. Upper panel – cross-sectional diagram of choroidal capillary 
     Lower panel – chorioretinal microcirculation organisation, oxygen gradients and actions 
of renal-angiotensin-aldosterone and endothelin system  
pO2 – partial pressure of oxygen; ON – optic nerve; RNFL – retinal nerve fibre layer; CRA – 
central retinal artery; CRV – central retinal vein; RAAS – renin-angiotensin-aldosterone 
system; ET – endothelin system; AT1R – angiotensin II type 1 receptors; ETAR – endothelin 
type A receptor; ETBR – endothelin type B receptor. 
 
Figure 3. Retinal vascular network geometric indices 
Retinal photographs (left panels) of the left eye using Canon CR-1 fundus camera with a field 
of view of 45° from a healthy volunteer (A) and patient with CKD (B). Arterial and venous 
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branches are binarised and segmented (middle panels) before being transformed into vessel 
(arterial) skeleton maps (right panels) for fractal dimension (Df) analyses. The vessel 
segmentation and skeleton maps demonstrate retinal vessel rarefaction in CKD compared to 
health that is not evident from the standard retinal photographs; health Df arteries = 1.47; CKD 
Df arteries = 1.18. Retinal photographs and segmentation images used under Creative 
Commons licence from https://www5.cs.fau.de/research/data/fundus-images/. Vessel 
skeleton map images kindly provided by Stephen Hogg (VAMPIRE® group, University of 
Dundee, United Kingdom). 
 
Figure 4. Deep imaging with OCT 
Right eye en-face confocal scanning laser ophthalmoscope (CLSO, left panels) and OCT 
(right panels) images using the Heidelberg SPECTRALIS® Spectral-Domain OCT machine 
(SD-OCT, Heidelberg Engineering, Heidelberg, Germany). in health (A, B & C) and CKD 
(D) with enhanced depth imaging (C & D) Scale bars: 200 µm. 
 
A. SD-OCT enables the identification of specific cell layers within the retina in high 
resolution. Left panel shows an en face CLSO image centred over the macula. Green line 
represents level and direction of cross section of corresponding OCT image running from left 
to right. Right panel is an OCT image demonstrating individual layers within the retina. 
Retinal thickness is defined as the area bounded by internal limiting membrane (ILM) and 
Bruch’s membrane (BM). 
 
B. Left panel is a CLSO image centred over the optic nerve head with line of cross-section 
(green) circled around the peri-papillary region. The dark blue line defines the distance from 
optic disc to fovea. Right panel is an OCT image demonstrating retinal thickness from the 
circular cross-section around the optic nerve head in the left image. The green line running 
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from left to right corresponds to the direction of cross-section of the green circle in left panel. 
Retinal nerve fibre layer thickness as defined as the area bordered by red and cyan lines. 
 
C. CSLO (left panel) and OCT with Enhanced Depth Imaging (EDI, right panel) in a healthy 
subject. EDI enables identification of deeper structures including the highly vascularised 
choroid. We measure choroidal thickness at 3 locatins: I = 2 mm nasal to the fovea, II = 
subfoveal, III = 2 mm temporal to the fovea. The corresponding locations on the macula are 
indicated by yellow arrows. 
 
D. CLSO (left panel) and OCT with EDI (right panel) in an age-, sex-matched subject with 
CKD demonstrating comparative thinning of the choroid at all 3 locations. The 
corresponding locations on the macula are indicated by yellow arrows. 
 
Figure 5. OCT angiography in health and chronic kidney disease 
Right eye en face OCT angiograms centred on the macula using the AngioVue® Imaging 
System (Optovue, Inc., Freemont, California) in a he lthy volunteer (A) and an age- and sex-
matched patient with proteinuric chronic kidney disea e (CKD, B). 
 
Left and middle panels: Peri-macular superficial and deep capillary plexuses with the foveal 
avascular zone (FAZ) represented by central black circular region. Compared to health, a 
wider FAZ and a disorganised branching pattern are evident in the CKD patient and are 
suggestive of rarefaction and microvascular damage. 
 
Right panels: Peri-macular superficial retinal vessels and the foveal avascular zone with 
colour map overlays of software-calculated vessel density.  Red denotes high vessel density; 
green denotes moderate vessel density; blue/navy denotes low vessel density. There is fewer 
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regions with high / moderate vessel density (red/green regions) CKD compared to health. 
Note these images are not from the same subjects as the left and middle panels.  
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Supplementary material 
Supplementary figure legends 
Supplementary figure 1. Alport syndrome-associated retinopathy.  
Ultra-wide field scanning laser ophthalmoscope photograph of left eye from a male patient 
with end-stage renal disease secondary to X-linked Alport syndrome. The characteristic dot-
and-fleck retinopathy is evident as green peri-macular deposits in the centre of the image. 
There is also associated loss of foveal reflex due to macular thinning. The presence of Alport-
associated retinopathy can help diagnosis, suggest inheritance patterns, identify those at risk 
of progressive CKD and differentiate from mimics such as thin GBM disease which has no 
associated retinal features.14, 15 
 
Supplementary figure 2. Retinal photography and fundus retinal calibre assessment 
A. Right eye digital retinal photograph using Canon CR-1 fundus camera with a field of view 
of 45°. 
 
B. Right eye scanning laser ophthalmoscope image centred over optic disc using the 
Heidelberg SPECTRALIS® Spectral-Domain OCT machine (SD-OCT, Heidelberg 
Engineering, Heidelberg, Germany). The centre of the optic disc is manually determined. A 
standard set of concentric circular measurement zones commonly used in the analysis of 
fundus camera images is mapped from this point as shown.  Zone ‘A’ is the area 0.5 to 1 
optic disc diameters away from the centre as bounded by the white dotted lines. The vessel 
analysis software VAMPIRE® (University of Dundee, United Kingdom) selects the six 
widest arterioles (red) and venules (blue) crossing zone A to calculate CRAE, CRVE and 
AVR.  
 
Supplementary figure 3. Retinal optical coherence tomography.  
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Blue lines represent fibre paths. Red lines represent optical paths. Green lines represent signal 
paths. Low coherence light (typically ~800 nm wavelength) is split into a sample beam and 
reference beam. The sample beam is shone onto the re ina and reflected back as ‘light 
echoes’. The reference beam is directed to a mirror positioned at a known distance from the 
light source. A range of ‘sample’ light echoes each return at different times depending on the 
distance of the reflecting tissue from the light source. Returning ‘sample’ and ‘reference’ 
light echoes are re-united and directed to a photodetector. An interference signal is detected 
when the time delays between the ‘sample’ and ‘reference’ light echoes is small, i.e. the 
distance of reference mirror matches the distance of the reflecting tissue. Moving the 
reference mirror (positions A to C) alters the distance the reference beam/echo must travel 
and thus changes the time delay between reference and sample echoes. At each new reference 
mirror distance, the reference echo time delay will closely match a different sample echo time 
delay, generating a new interference signal corresponding to a deeper/shallower reflecting 
tissue layer. Sequential movement of reference mirror allows the construction of a single 
interference depth profile: the A-scan. A-scans obtain depth profiles along the z-axis. The 
lateral scanning mirror is rotated through positions 1 to 4 along the x–axis to obtain 
sequential adjacent A-scans which are used to generate a single horizontal B-scan. The 
vertical scanning mirror is elevated/lowered along the y-axis to obtain horizontal B-scans at 
multiple levels. B-scans can then be stacked to create a volume scan (Supplementary videos 
1 and 2).  
 
Supplementary figure 4. Retinal layer segmentation by OCT. Close up of horizontal line 
OCT scan through the macula of the right eye with automated segmentation of individual 
retinal layers. RNFL – retinal nerve fibre layer, GCL – ganglion cell layer, IPL – inner 
plexiform layer, INL – inner nuclear layer, OPL – outer plexiform layer, ONL – outer nuclear 
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layer, PR – photoreceptor layer, RPE – retinal pigment epithelium, BM – Bruch’s membrane, 
CH – choroid. 
 
Supplementary figure 5. OCT angiography  
Right eye 3 x 3mm OCT angiograms en face (left panels) and in cross-section (right panels), 
centred on the macula, using the AngioVue® Imaging System (Optovue, Inc., Freemont, 
California). 
 
A. Left panel: The peri-macular superficial capillary plexus and the foveal avascular zone. 
Right panel: OCT image showing the level and boundaries of retinal layer segmentation the 
corresponds to en face angiogram. Red and green lines define the upper and lower limits 
respectively, of the segmentation band. 
 
B. Left panel: The peri-macular deep capillary plexus and the foveal avascular zone. Right 
panel: OCT image showing the level and boundaries of deeper retinal layer segmentation the 
corresponds to en face angiogram. Red and green lines define the upper and lower limits 
respectively, of the segmentation band. 
 
C. Left panel: The outer (deepest) retinal layers are relatively avascular as shown and is thus 
dependent on passive oxygenation from the deeper choroidal circulation. Right panel: OCT 
image showing the level and boundaries of outer retinal layer segmentation the corresponds 
to en face angiogram. Red lines define the upper and lower limits of the segmentation band. 
 
D. Left panel: The subfoveal choriocapillaris is a dense mesh of capillaries underneath the 
pigment epithelium. Despite advances in OCT-A, imaging discrete vessels here remains 
challenging. Right panel: OCT image showing the level and boundaries of choriocapillaris 
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segmentation the corresponds to en face angiogram. Red and green lines define the upper and 
lower limits respectively, of the segmentation band. 
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Supplementary video legends 
Supplementary video 1. OCT in health 
Video of a 3-dimensional rendered macular volume OCT scan of right eye from a healthy 
volunteer.  
 
Supplementary video 2. OCT in CKD 
Video of a 3-dimensional rendered macular volume OCT scan of right eye from an age- and 
sex-matched subject with CKD. Note marked thinning of choroidal vascular lying underneath 
the retina. 
 
Supplementary video 3. OCT angiography of macula in health  
Video of sequential ‘layer by layer’ OCT angiograms centred on macula of right eye from a 
healthy volunteer. The track bar on the left-hand si e relates colour-coded anatomic 
localisation of retinal regions that correspond to the angiograms shown in main panel.  
 
Supplementary video 4. OCT angiography of optic disc in health  
Video of sequential ‘layer by layer’ OCT angiograms centred on fundus of right eye from a 
healthy volunteer. The track bar on the left-hand si e relates colour-coded anatomic 
localisation of retinal regions that correspond to the angiograms shown in main panel.  
 
Supplementary information is available on Kidney Inter ational's web site 
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